Shares of BioLineRx Ltd. skyrocketed 34% on Oct.
Bioline RX Ltd (NASDAQ:BLRX) announced that BVF Partners L.P.
Bioline RX Ltd (NASDAQ:BLRX) investors are heading for the hills after the the drug maker announced that it has commenced an underwritten public offering …
Bioline RX Ltd (NASDAQ:BLRX) reported partial results data from its open-label Phase 2 trial for BL-8040 as a novel monotherapy approach for the …
Bioline RX Ltd (NASDAQ:BLRX) gave investors reason for excitement today after announcing the initiation of a second Phase 2a trial investigating BL-8040 in combination …
Bioline RX Ltd (NASDAQ:BLRX) reports its financial results for the third quarter ended September 30, 2016. Highlights and achievements during third quarter of 2016 …
Bioline RX Ltd (NASDAQ:BLRX) announced that it has signed an exclusive, worldwide agreement with Yissum Research Development Company of the Hebrew University of …
Bioline RX Ltd (NASDAQ:BLRX) disclosed positive Phase 2a correlative data, as well as detailed mechanism-of-action data, for BL-8040, the Company’s leading oncology platform, that …
Bioline RX Ltd (NASDAQ:BLRX) announced today that data on BL-8040, the Company’s leading oncology platform, have been accepted for presentations at the 58th …
Healthcare analysts chimed in on Bioline RX Ltd (NASDAQ:BLRX) and Endo International plc – Ordinary Shares (NASDAQ:ENDP), as both stocks are among the top performers today. The …
